The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury
Open accessAbstract
Background: Myocardial ischemia-reperfusion (MI/R) injury is a significant clinical problem without effective therapy. Unbiased omics approaches may reveal key MI/R mediators to initiate MI/R injury. Methods: We used a dynamic transcriptome analysis of mouse heart exposed to various MI/R periods to identify S100a8/a9 as an early mediator. Using loss/gain-of-function approaches to understand the role of S100a8/a9 in MI/R injury, we explored the mechanisms through transcriptome and functional experiment. Dynamic serum S100a8/a9 levels were measured in patients with acute myocardial infarction before and after percutaneous coronary intervention. Patients were prospectively followed for the occurrence of major adverse cardiovascular events. Results: S100a8/a9 was identified as the most significantly upregulated gene during the early reperfusion stage. Knockout of S100a9 markedly decreased cardiomyocyte death and improved heart function, whereas hematopoietic overexpression of S100a9 exacerbated MI/R injury. Transcriptome/functional studies revealed that S100a8/a9 caused mitochondrial respiratory dysfunction in cardiomyocytes. Mechanistically, S100a8/a9 downregulated NDUF gene expression with subsequent mitochondrial complex I inhibition via Toll-like receptor 4/Erk–mediated Pparg coactivator 1 alpha/nuclear respiratory factor 1 signaling suppression. Administration of S100a9 neutralizing antibody significantly reduced MI/R injury and improved cardiac function. Finally, we demonstrated that serum S100a8/a9 levels were significantly increased 1 day after percutaneous coronary intervention in patients with acute myocardial infarction, and elevated S100a8/a9 levels were associated with the incidence of major adverse cardiovascular events. Conclusions: Our study identified S100a8/a9 as a master regulator causing cardiomyocyte death in the early stage of MI/R injury via the suppression of mitochondrial function. Targeting S100a8/a9-intiated signaling may represent a novel therapeutic intervention against MI/R injury. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT03752515
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Self-citationYellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Hausenloy, D. J., & Yellon, D. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62874 · Cited by 2,357
Reed, G. W., Rossi, J. E., & Cannon, C. P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30677-8 · Cited by 1,507
Wang, S., Song, R., Wang, Z., Jing, Z., Wang, S., & Ma, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01298 · Cited by 1,450
Evolving Therapies for Myocardial Ischemia/Reperfusion Injury
Ibáñez, B., Heusch, G., Ovize, M., & Van de Werf, F. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.032 · Cited by 1,009
Transcriptional control of mitochondrial biogenesis: the central role of PGC-1
Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn098 · Cited by 932
Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M., Nacken, W., Sorg, C., Vogl, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080132 · Cited by 902
Foell, D., Wittkowski, H., Vogl, T., & Roth, J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306170 · Cited by 879
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Cung, T.-T., Morel, O., Cayla, G., Rioufol, G., Garcia-Dorado, D., Angoulvant, D., Bonnefoy-Cudraz, E., Guérin, P., Elbaz, M., Delarche, N., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505489 · Cited by 713
Ide, T., Tsutsui, H., Kinugawa, S., Utsumi, H., Kang, D., Hattori, N., Uchida, K., Arimura, K.-I., Egashira, K., & Takeshita, A. (1999) · Circulation Research · doi:10.1161/01.res.85.4.357 · Cited by 700
Heusch, G., & Gersh, B. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw224 · Cited by 676
Paradies, G., Petrosillo, G., Pistolese, M., Di Venosa, N., Federici, A., & Ruggiero, F. M. (2004) · Circulation Research · doi:10.1161/01.res.0000109416.56608.64 · Cited by 468
S100A8/A9: From basic science to clinical application
Pruenster, M., Vogl, T., Roth, J., & Sperandio, M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.015 · Cited by 450
Arany, Z., Novikov, M., Chin, S., Ma, Y., Rosenzweig, A., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603615103 · Cited by 374
Paradies, G., Petrosillo, G., Pistolese, M., & Ruggiero, F. M. (2002) · Gene · doi:10.1016/s0378-1119(01)00814-9 · Cited by 372
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Comi, G., Jeffery, D., Kappos, L., Montalban, X., Boyko, A., Rocca, M. A., & Filippi, M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1104318 · Cited by 364
Björk, P., Björk, A., Vogl, T., Stenström, M., Liberg, D., Olsson, A., Roth, J., Ivars, F., & Leanderson, T. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000097 · Cited by 356
Hausenloy, D. J., Garcia-Dorado, D., Bøtker, H. E., Davidson, S. M., Downey, J., Engel, F. B., Jennings, R., Lecour, S., Leor, J., Madonna, R., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx049 · Cited by 356
Manitz, M.-P., Horst, B., Seeliger, S., Strey, A., Skryabin, B. V., Gunzer, M., Frings, W., Schünlau, F., Roth, J., Sorg, C., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1034-1043.2003 · Cited by 319
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage
Perier, C., Tieu, K., Guégan, C., Caspersen, C., Jackson-Lewis, V., Carelli, V., Martinuzzi, A., Hirano, M., Przedborski, S., & Vila, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508215102 · Cited by 308
Jin, Z., Wei, W., Yang, M., Du, Y., & Wan, Y. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.011 · Cited by 283
Inflammation in Myocardial Diseases
Marchant, D. J., Boyd, J. H., Lin, D. C., Granville, D. J., Garmaroudi, F. S., & McManus, B. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.243170 · Cited by 282
Anti‐inflammatory therapies in myocardial infarction: failures, hopes and challenges
Huang, S., & Frangogiannis, N. G. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14155 · Cited by 282
Mitochondria as a Drug Target in Ischemic Heart Disease and Cardiomyopathy
Walters, A. M., Porter, G. A., & Brookes, P. S. (2012) · Circulation Research · doi:10.1161/circresaha.112.265660 · Cited by 271
Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis
SULIMAN, H., WELTYWOLF, K., CARRAWAY, M., TATRO, L., & PIANTADOSI, C. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.07.005 · Cited by 269
Respiratory chain complex I deficiency: An underdiagnosed energy generation disorder
Kirby, D. M., Crawford, M., Cleary, M. A., Dahl, H.-H. M., Dennett, X., & Thorburn, D. R. (1999) · Neurology · doi:10.1212/wnl.52.6.1255 · Cited by 266
Oxidative Stress During Myocardial Ischaemia and Heart Failure
Ferrari, R., Guardigli, G., Mele, D., Percoco, G., Ceconi, C., & Curello, S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384718 · Cited by 242
Myeloid Cell Function in MRP-14 (S100A9) Null Mice
Hobbs, J. A. R., May, R., Tanousis, K., McNeill, E., Mathies, M., Gebhardt, C., Henderson, R., Robinson, M. J., & Hogg, N. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2564-2576.2003 · Cited by 224
Yu, L., Gong, B., Duan, W., Fan, C., Zhang, J., Li, Z., Xue, X., Xu, Y., Meng, D., Li, B., et al. (2017) · Scientific Reports · doi:10.1038/srep41337 · Cited by 205
Self-citationXia, Y., Buja, L. M., Scarpulla, R. C., & McMillin, J. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11399 · Cited by 161
Volz, H. C., Laohachewin, D., Seidel, C., Lasitschka, F., Keilbach, K., Wienbrandt, A. R., Andrassy, J., Bierhaus, A., Kaya, Z., Katus, H. A., et al. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0250-z · Cited by 133
Wu, Y., Li, Y., Zhang, C., Xi, A., Wang, Y.-L., Cui, W., Li, H., & Du, J. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02843 · Cited by 133
Self-citationSchilling, J. D., Lai, L., Sambandam, N., Dey, C. E., Leone, T. C., & Kelly, D. P. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959833 · Cited by 125
Hardy, L., Clark, J. B., Darley-Usmar, V. M., Smith, D. R., & Stone, D. (1991) · Biochemical Journal · doi:10.1042/bj2740133 · Cited by 123
Cotoi, O. S., Dunér, P., Ko, N., Hedblad, B., Nilsson, J. Å., Björkbacka, H., & Șchiopu, A. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302432 · Cited by 112
Gadicherla, A. K., Stowe, D. F., Antholine, W. E., Yang, M., & Camara, A. K. S. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.11.021 · Cited by 89
Mitochondria-assisted cell suicide: a license to kill
Regula, K. M. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00118-4 · Cited by 83
A phase II study of laquinimod in Crohn's disease
D’Haens, G., Sandborn, W. J., Colombel, J., Rutgeerts, P. J., Brown, K. A., Barkay, H., Sakov, A., Haviv, A., & Feagan, B. G. (2014) · Gut · doi:10.1136/gutjnl-2014-307118 · Cited by 83
Ashabi, G., Ramin, M., Azizi, P., Taslimi, Z., Alamdary, S. Z., Haghparast, A., Ansari, N., Motamedi, F., & Khodagholi, F. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.04.006 · Cited by 65
Lebon, S., Minai, L., Chrétien, D., Corcos, J., Serre, V., Kadhom, N., Steffann, J., Pauchard, J.-Y., Münnich, A., Bonnefont, J., et al. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.05.010 · Cited by 49
RAGE-Dependent Regulation of Calcium-Binding Proteins S100A8 and S100A9 in Human THP-1
Eggers, K., Sikora, K., Lorenz, M., Taubert, T., Moobed, M., Baumann, G., Stangl, K., & Stangl, V. (2011) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0030-1268426 · Cited by 38
The hetero‐oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant
Nacken, W., & Kerkhoff, C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.09.060 · Cited by 34
The Elevated Serum S100A8/A9 During Acute Myocardial Infarction Is Not of Cardiac Myocyte Origin
Du, C., Yang, L., Han, J., Yang, J., Yao, X., Hu, X., & Hu, S. (2011) · Inflammation · doi:10.1007/s10753-011-9375-8 · Cited by 14
Cited by
Cai, W., Liu, L., Shi, X., Liu, Y., Wang, J., Fang, X., Chen, Z., Ai, D., Zhu, Y., & Zhang, X. (2023) · Circulation · doi:10.1161/circulationaha.122.060257 · Cited by 445
Self-citationWang, Z., Yao, M., Jiang, L., Wang, L., Yang, Y., Wang, Q., Qian, X., Zhao, Y., & Qian, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113572 · Cited by 286
Spatiotemporal transcriptomics elucidates the pathogenesis of fulminant viral myocarditis
Li, H., Chen, X., Wang, J. J., Shen, J., Abuduwufuer, K., Zhang, Z., Dong, Z., Wen, Z., He, J., Chen, S., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02143-9 · Cited by 40
Metadata
- Authors
- Li, Y., Chen, B., Yang, X., Zhang, C., Jiao, Y., Li, P., Liu, Y., Li, Z., Qiao, B., Bond Lau, W., Ma, X.-L., & Du, J.
- Venue
- Circulation
- Published
- 2019-08-27
- Volume
- 140
- Issue
- 9
- Pages
- 751-764
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2953193043
- Cited by
- 314
- References
- 46
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.